Roles for c-Abl in postoperative neurodegeneration

被引:4
作者
Feng, Long [1 ]
Fu, Shihui [2 ,3 ]
Yao, Yao [4 ,5 ,6 ]
Li, Yulong [3 ]
Xu, Longhe [7 ]
Zhao, Yali [8 ]
Luo, Leiming [3 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Anesthesiol, Hainan Hosp, Sanya, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Hainan Hosp, Sanya, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China
[4] Duke Univ, Sch Med, Ctr Study Aging & Human Dev, Durham, NC USA
[5] Duke Univ, Sch Med, Div Geriatr, Durham, NC USA
[6] Peking Univ, Natl Sch Dev, Ctr Hlth Aging & Dev Studies, Beijing, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 3, Dept Anesthesiol, Beijing, Peoples R China
[8] Chinese Peoples Liberat Army Gen Hosp, Hainan Hosp, Cent Lab, Sanya, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金; 中国博士后科学基金;
关键词
Alzheimer?s disease; Nonreceptor tyrosine kinase; Oxidative stress; Parkinson?s disease; Postoperative cognitive dysfunction; Postoperative neurodegeneration; TYROSINE KINASE; COGNITIVE DYSFUNCTION; OXIDATIVE STRESS; DNA-DAMAGE; PARKINSONS-DISEASE; NEURONAL DAMAGE; ALPHA-SYNUCLEIN; UP-REGULATION; PHOSPHORYLATION; ACTIVATION;
D O I
10.7150/ijms.73740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nonreceptor tyrosine kinase c-Abl is inactive under normal conditions. Upon activation, c-Abl regulates signaling pathways related to cytoskeletal reorganization. It plays a vital role in modulating cell protrusion, cell migration, morphogenesis, adhesion, endocytosis and phagocytosis. A large number of studies have also found that abnormally activated c-Abl plays an important role in a variety of pathologies, including various inflammatory diseases and neurodegenerative diseases. c-Abl also plays a crucial role in neurodevelopment and neurodegenerative diseases, mainly through mechanisms such as neuroinflammation, oxidative stress (OS), and Tau protein phosphorylation. Inhibiting expression or activity of this kinase has certain neuroprotective and anti-inflammatory effects and can also improve cognition and behavior. Blockers of this kinase may have good preventive and treatment effects on neurodegenerative diseases. Cognitive dysfunction after anesthesia is also closely related to the abovementioned mechanisms. We infer that alterations in the expression and activity of c-Abl may underlie postoperative cognitive dysfunction (POCD). This article summarizes the current understanding and research progress on the mechanisms by which c-Abl may be related to postoperative neurodegeneration.
引用
收藏
页码:1753 / 1761
页数:9
相关论文
共 50 条
[21]   NF-κB activity is constitutively elevated in c-Abl null fibroblasts [J].
Liberatore, Rachel A. ;
Goff, Stephen P. ;
Nunes, Irene .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (42) :17823-17828
[22]   c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson's Disease [J].
Lindholm, Dan ;
Pham, Dan D. ;
Cascone, Annunziata ;
Eriksson, Ove ;
Wennerberg, Krister ;
Saarma, Mart .
FRONTIERS IN AGING NEUROSCIENCE, 2016, 8
[23]   Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast Cancer [J].
Zhao, Huajun ;
Ou-Yang, Fu ;
Chen, I-Fen ;
Hou, Ming-Feng ;
Yuan, Shyng-Shiou F. ;
Chang, Hsueh-Ling ;
Lee, Yi-Chen ;
Plattner, Rina ;
Waltz, Susan E. ;
Ho, Shuk-Mei ;
Sims, Jonathan ;
Wang, Shao-Chun .
NEOPLASIA, 2010, 12 (03) :214-U15
[24]   c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases [J].
Gutierrez, Daniela A. ;
Chandia-Cristi, America ;
Yanez, Maria Jose ;
Zanlungo, Silvana ;
Alvarez, Alejandra R. .
NEURAL REGENERATION RESEARCH, 2023, 18 (02) :237-243
[25]   c-Abl is required for staurosporine-induced caspase activity [J].
Oxhorn, BC ;
Sanguinetti, AR ;
Mastick, CC ;
Buxton, ILO .
Proceedings of the Western Pharmacology Society, Vol 48, 2005, 48 :110-117
[26]   Altered Subcellular Distribution of c-Abl in Alzheimer's Disease [J].
Jing, Zheng ;
Caltagarone, John ;
Bowser, Robert .
JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) :409-422
[27]   c-Abl in Neurodegenerative Disease [J].
Sarah D. Schlatterer ;
Christopher M. Acker ;
Peter Davies .
Journal of Molecular Neuroscience, 2011, 45 :445-452
[28]   c-Abl/TFEB Pathway Activation as a Common Pathogenic Mechanism in Lysosomal Storage Diseases: Therapeutic Potential of c-Abl Inhibitors [J].
Guerra, Miguel V. ;
Castro, Juan ;
Moreno, Antonio ;
Balboa, Elisa ;
Marugan, Juan J. ;
Alvarez, Alejandra R. ;
Zanlungo, Silvana .
ANTIOXIDANTS, 2025, 14 (05)
[29]   The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model [J].
Lee, Saebom ;
Kim, Sangjune ;
Park, Yong Joo ;
Yun, Seung Pil ;
Kwon, Seung-Hwan ;
Kim, Donghoon ;
Kim, Dong Yeon ;
Shin, Jae Soo ;
Cho, Dae Jin ;
Lee, Gong Yeal ;
Ju, Hyun Soo ;
Yun, Hyo Jung ;
Park, Jae Hong ;
Kim, Wonjoong Richard ;
Jung, Eun Ah ;
Lee, Seulki ;
Ko, Han Seok .
HUMAN MOLECULAR GENETICS, 2018, 27 (13) :2344-2356
[30]   Role of c-Abl tyrosine kinase in smooth muscle cell migration [J].
Cleary, Rachel A. ;
Wang, Ruping ;
Waqar, Omar ;
Singer, Harold A. ;
Tang, Dale D. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2014, 306 (08) :C753-C761